9WM
ABBV icon

9258 Wealth Management’s AbbVie ABBV Stock Holding History

9258 Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.48M Buy
17,598
+62
+0.4% +$11.6K 0.51% 39
2024
Q2 		$3.01M Buy
17,536
+353
+2% +$58.5K 0.46% 44
2024
Q1 		$3.13M Buy
17,183
+274
+2% +$47.2K 0.49% 43
2023
Q4 		$2.62M Buy
16,909
+283
+2% +$41.3K 0.46% 46
2023
Q3 		$2.48M Sell
16,626
-420
-2% -$61.7K 0.48% 47
2023
Q2 		$2.3M Sell
17,046
-155
-0.9% -$22.7K 0.43% 48
2023
Q1 		$2.74M Sell
17,201
-30
-0.2% -$4.59K 0.55% 39
2022
Q4 		$2.78M Sell
17,231
-1,009
-6% -$155K 0.6% 36
2022
Q3 		$2.45M Sell
18,240
-643
-3% -$92.3K 0.63% 35
2022
Q2 		$2.89M Buy
18,883
+250
+1% +$38.2K 0.74% 26
2022
Q1 		$3.02M Buy
18,633
+1,209
+7% +$176K 0.7% 28
2021
Q4 		$2.36M Buy
17,424
+1,040
+6% +$123K 0.54% 32
2021
Q3 		$1.77M Buy
16,384
+677
+4% +$77.4K 0.47% 36
2021
Q2 		$1.77M Buy
15,707
+236
+2% +$26.6K 0.48% 39
2021
Q1 		$1.67M Buy
15,471
+342
+2% +$36.6K 0.5% 37
2020
Q4 		$1.62M Sell
15,129
-475
-3% -$45.6K 0.53% 33
2020
Q3 		$1.33M Sell
15,604
-5
-0% -$471 0.5% 36
2020
Q2 		$1.53M Buy
15,609
+807
+5% +$71.1K 0.62% 31
2020
Q1 		$1.25M Sell
14,802
-628
-4% -$53.5K 0.55% 39
2019
Q4 		$1.37M Buy
15,430
+9,502
+160% +$789K 0.5% 42
2019
Q3 		$449K Buy
5,928
+58
+1% +$3.98K 0.35% 96
2019
Q2 		$427K Buy
5,870
+274
+5% +$21.5K 0.34% 102
2019
Q1 		$451K Buy
5,596
+172
+3% +$14.1K 0.38% 86
2018
Q4 		$500K Buy
+5,424
New +$477K 0.48% 68

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

9258 Wealth Management's ABBV Position: Q3 2024 in Review

9258 Wealth Management increased its AbbVie (ABBV) stake by 0.35% in Q3 2024, buying an estimated $11.6K and bringing the position to 17,598 shares worth $3.48M. The position accounts for 0.51% of the portfolio, ranked #39.

9258 Wealth Management first reported a position in ABBV in Q4 2018 and has held it in 24 quarters since. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • 9258 Wealth Management held 17,598 shares of AbbVie worth $3.48M as of Q3 2024.
  • 9258 Wealth Management bought 62 AbbVie shares in Q3 2024, an estimated $11.6K.
  • AbbVie made up 0.51% of 9258 Wealth Management's portfolio in Q3 2024, its #39 holding.
  • 9258 Wealth Management first reported a position in AbbVie in Q4 2018 and has held it in 24 quarters since.
  • 3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on 9258 Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.